Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach.
暂无分享,去创建一个
[1] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[2] M. Dickson,et al. Key factors in the rising cost of new drug discovery and development , 2004, Nature Reviews Drug Discovery.
[3] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[4] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[5] M. Levandowsky,et al. Distance between Sets , 1971, Nature.
[6] A. M. Almerico,et al. A3 adenosine receptor: homology modeling and 3D-QSAR studies. , 2013, Journal of molecular graphics & modelling.
[7] C. Chong,et al. New uses for old drugs , 2007, Nature.
[8] M. Tutone,et al. Multivariate analysis in the identification of biological targets for designed molecular structures: the BIOTA protocol. , 2014, European journal of medicinal chemistry.
[9] John P. Overington,et al. Global Analysis of Small Molecule Binding to Related Protein Targets , 2012, PLoS Comput. Biol..
[10] Sudipto Mukherjee,et al. Docking Validation Resources: Protein Family and Ligand Flexibility Experiments , 2010, J. Chem. Inf. Model..
[11] Woody Sherman,et al. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.
[12] M. Tutone,et al. Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation , 2015, Journal of drug targeting.
[13] M. L. Jones,et al. PDBsum: a Web-based database of summaries and analyses of all PDB structures. , 1997, Trends in biochemical sciences.
[14] J. DiMasi,et al. Risks in new drug development: Approval success rates for investigational drugs , 2001, Clinical pharmacology and therapeutics.
[15] Anna Maria Almerico,et al. Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target , 2014, Journal of Molecular Modeling.
[16] Mark McGann,et al. FRED and HYBRID docking performance on standardized datasets , 2012, Journal of Computer-Aided Molecular Design.
[17] A. M. Almerico,et al. Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors , 2012, Journal of Molecular Modeling.
[18] A. Lauria,et al. Lead optimization through VLAK protocol: new annelated pyrrolo-pyrimidine derivatives as antitumor agents. , 2012, European journal of medicinal chemistry.
[19] Anna Maria Almerico,et al. Docking and multivariate methods to explore HIV-1 drug-resistance: a comparative analysis , 2008, J. Comput. Aided Mol. Des..
[20] A. Lauria,et al. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol. , 2013, European journal of medicinal chemistry.
[21] David E Nichols,et al. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation , 2009, Behavioural pharmacology.
[22] Randall T Peterson,et al. Chemical biology and the limits of reductionism. , 2008, Nature chemical biology.
[23] M. Tutone,et al. Phytochemical Indicaxanthin Inhibits Colon Cancer Cell Growth and Affects the DNA Methylation Status by Influencing Epigenetically Modifying Enzyme Expression and Activity , 2015, Lifestyle Genomics.
[24] Anna Maria Almerico,et al. IKK-beta inhibitors: an analysis of drug-receptor interaction by using molecular docking and pharmacophore 3D-QSAR approaches. , 2010, Journal of molecular graphics & modelling.
[25] D. Rogers,et al. Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up , 2005, Journal of biomolecular screening.
[26] M. Tutone,et al. 3D-QSAR pharmacophore modeling and in silico screening of new Bcl-xl inhibitors. , 2010, European journal of medicinal chemistry.
[27] A. M. Almerico,et al. Indicaxanthin from Opuntia ficus-indica Crosses the Blood-Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. , 2015, Journal of agricultural and food chemistry.
[28] Antonio Carrieri,et al. Recent trends and future prospects in computational GPCR drug discovery: from virtual screening to polypharmacology. , 2013, Current topics in medicinal chemistry.
[29] A. M. Almerico,et al. Virtual lock-and-key approach: the in silico revival of Fischer model by means of molecular descriptors. , 2011, European journal of medicinal chemistry.
[30] Shuxing Zhang,et al. Polypharmacology: drug discovery for the future , 2013, Expert review of clinical pharmacology.
[31] Andrew C. Good,et al. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..
[32] Xiang-Qun Xie,et al. Computational target fishing: what should chemogenomics researchers expect for the future of in silico drug design and discovery? , 2014, Future medicinal chemistry.
[33] Angelo D. Favia,et al. Protein promiscuity and its implications for biotechnology , 2009, Nature Biotechnology.
[34] D. Marona-Lewicka,et al. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action , 2007, Pharmacology Biochemistry and Behavior.
[35] Anna Maria Almerico,et al. Molecular dynamics studies on Mdm2 complexes: an analysis of the inhibitor influence. , 2012, Biochemical and biophysical research communications.